As viruses continue to change, vaccines must be updated.

This clinical trial will help us learn if an updated COVID-19 vaccine is safe, and if it can help the immune system defend against new variants of the virus in healthy adults who do not have risk factors for severe COVID-19.

This clinical trial is enrolling healthy adults who:

• Are [50 to 64] years of age
• Have not tested positive for COVID-19 or received a COVID-19 vaccine within the last 3 months
• Do not have a medical condition that increases the risk of severe COVID-19 such as diabetes, cancer, obesity, chronic kidney disease, COPD, depression, etc.

There are other requirements that the study team will discuss with you.

What to expect:

• Participation lasts for at least [6] months and includes at least [4] study visits (some visits may be conducted by telephone).
• The study vaccine and study-related procedures will be provided at no cost. Participants are paid for completing on-site study visits.

Ready to learn more?

Contact our study team:

Ron Ruhaak, Research Manager

Ron@eastwestresearch.com

Call/Text: (808) 440-4426

Taking part in this clinical trial may help improve vaccine protection not only for you, but also others in the future.